|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 10057 |
FusionGeneSummary for DLD_SHPRH |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: DLD_SHPRH | Fusion gene ID: 10057 | Hgene | Tgene | Gene symbol | DLD | SHPRH | Gene ID | 60343 | 257218 |
| Gene name | family with sequence similarity 3 member A | SNF2 histone linker PHD RING helicase | |
| Synonyms | 2.19|DLD|DXS560S|XAP-7 | bA545I5.2 | |
| Cytomap | Xq28 | 6q24.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein FAM3Acytokine-like protein 2-19 | E3 ubiquitin-protein ligase SHPRH2610103K11RikRING-type E3 ubiquitin transferase SHPRHSNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligaseSNF2, histone-linker, PHD and RING finger domain-containing helicase | |
| Modification date | 20180522 | 20180519 | |
| UniProtAcc | P09622 | Q149N8 | |
| Ensembl transtripts involved in fusion gene | ENST00000205402, ENST00000537148, ENST00000440410, ENST00000437604, ENST00000494441, | ENST00000367505, ENST00000367503, ENST00000438092, ENST00000275233, | |
| Fusion gene scores | * DoF score | 4 X 4 X 4=64 | 3 X 3 X 2=18 |
| # samples | 4 | 3 | |
| ** MAII score | log2(4/64*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: DLD [Title/Abstract] AND SHPRH [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | DLD | GO:0019732 | antifungal humoral response | 18212107 |
| Hgene | DLD | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 18212107 |
| Hgene | DLD | GO:1905035 | negative regulation of antifungal innate immune response | 18212107 |
| Tgene | SHPRH | GO:0000209 | protein polyubiquitination | 17108083 |
| Tgene | SHPRH | GO:0006974 | cellular response to DNA damage stimulus | 25023518 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | SARC | TCGA-DX-A6BH-01A | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000205402 | ENST00000367505 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 5CDS-intron | ENST00000205402 | ENST00000367503 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 5CDS-intron | ENST00000205402 | ENST00000438092 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 5CDS-intron | ENST00000205402 | ENST00000275233 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| intron-intron | ENST00000537148 | ENST00000367505 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| intron-intron | ENST00000537148 | ENST00000367503 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| intron-intron | ENST00000537148 | ENST00000438092 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| intron-intron | ENST00000537148 | ENST00000275233 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| intron-intron | ENST00000440410 | ENST00000367505 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| intron-intron | ENST00000440410 | ENST00000367503 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| intron-intron | ENST00000440410 | ENST00000438092 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| intron-intron | ENST00000440410 | ENST00000275233 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 5CDS-intron | ENST00000437604 | ENST00000367505 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 5CDS-intron | ENST00000437604 | ENST00000367503 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 5CDS-intron | ENST00000437604 | ENST00000438092 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 5CDS-intron | ENST00000437604 | ENST00000275233 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 3UTR-intron | ENST00000494441 | ENST00000367505 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 3UTR-intron | ENST00000494441 | ENST00000367503 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 3UTR-intron | ENST00000494441 | ENST00000438092 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
| 3UTR-intron | ENST00000494441 | ENST00000275233 | DLD | chr7 | 107542838 | + | SHPRH | chr6 | 146185627 | - |
Top |
FusionProtFeatures for DLD_SHPRH |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| DLD | SHPRH |
| Lipoamide dehydrogenase is a component of the glycinecleavage system as well as an E3 component of three alpha-ketoaciddehydrogenase complexes (pyruvate-, alpha-ketoglutarate-, andbranched-chain amino acid-dehydrogenase complex) (PubMed:15712224,PubMed:16442803, PubMed:16770810, PubMed:17404228,PubMed:20160912, PubMed:20385101). The 2-oxoglutaratedehydrogenase complex is mainly active in the mitochondrion(PubMed:29211711). A fraction of the 2-oxoglutarate dehydrogenasecomplex also localizes in the nucleus and is required for lysinesuccinylation of histones: associates with KAT2A on chromatin andprovides succinyl-CoA to histone succinyltransferase KAT2A(PubMed:29211711). In monomeric form may have additionalmoonlighting function as serine protease (PubMed:17404228).Involved in the hyperactivation of spermatazoa during capacitationand in the spermatazoal acrosome reaction (By similarity).{ECO:0000250|UniProtKB:Q811C4, ECO:0000269|PubMed:15712224,ECO:0000269|PubMed:16442803, ECO:0000269|PubMed:16770810,ECO:0000269|PubMed:17404228, ECO:0000269|PubMed:20160912,ECO:0000269|PubMed:20385101, ECO:0000269|PubMed:29211711}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for DLD_SHPRH |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for DLD_SHPRH |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| DLD | OGDH, PSMD4, SIRT7, SLC2A4, DBT, DLAT, NDUFB5, NDUFA9, UQCRC2, UBAP2, MRPL13, MRPL11, ETFB, MRPL23, MRPL37, AK2, UQCRC1, NONO, MRPL42, GGH, FN1, ATF2, CKB, ASS1, CNDP2, DPP3, PEPD, TNFAIP8, LDHA, RPL23, ASB15, HUWE1, FUS, SIAH1, PDHB, DLST, OGDHL, HLTF, PDK3, SORL1, PARS2, PDHA1, NFS1, FBXO21, BTRC, FBXW11, DHTKD1, MRPS36, SIAH2, C7orf55, PCBP3, PDHX, SLX4IP, AIFM1, ALDOC, ATP1B1, CAPZB, CTH, ACAT1, ATP1B3, CSTF1, HSD17B10, NDUFS2, SDHA, VTA1, FH, HNRNPH2, HSDL2, ISYNA1, MRPL9, NUDT21, SDHB, SNX12, STIP1, SUCLG2, TOMM40, UCHL3, NTRK1, STAT5B, HDAC6, PRDX2, EEF1B2, PTBP1, PSME3, RPA3, YARS, PDIA6, HSP90B1, EIF3I, SERBP1, HPRT1, YWHAE, UBE2N, ARF1, CACYBP, PCMT1, APRT, UBE2M, PSMD11, DCD, NAA50, RUVBL1, KCTD12, BANF1, CDK1, ETFA, SUB1, PRDX3, CCT8, PSMD2, EEF1G, PSMC4, EIF3G, IDH3A, PRDX6, CLTB, CCT2, OAT, C14orf166, YWHAQ, YWHAZ, YWHAB, SERPINH1, DTYMK, EEF2, MGME1, PSMC1, COPZ1, VCP, ARF4, OTUB1, PABPC1, HSD17B4, PSMD7, XRCC6, PPP1CA, LDHB, AP1B1, UBE2K, MTHFD2, EIF3B, EIF3F, COPE, RUVBL2, INIP, AP1S2, ACP1, TRAP1, SEC23A, NUDC, PSMC6, EEF1D, PSMD10, RPL30, PRKAR2A, PAFAH1B3, PPA1, EEF1E1, PBDC1, UBA1, DNAJA2, CAP1, DIABLO, PAICS, SF3B6, KPNB1, DARS, PSMD13, PSMC3, ATG3, TMPO, PGAM1, CDC42, MRPS18B, RANGAP1, BUB3, SAR1A, G3BP1, RPA2, RAB1A, GSTP1, PLS3, BAG2, H1FX, SHMT2, RTCB, PDCD6IP, SET, DYNC1LI1, EIF3M, POLR2H, ACTR1A, ACBD3, ABHD10, TTC4, CCT7, PSMD6, ILF2, NAA10, VAT1, EIF2S1, OLA1, EPRS, PDCL3, PTGES3, COPS4, TSFM, SKP1, YWHAG, RPL12, FAM98B, ANP32A, CHORDC1, HYOU1, SRP72, PPP2R1A, AP1M1, DCTPP1, UFM1, RBBP7, RBBP4, POLR1C, UCK2, PSPC1, COPS7B, RPA1, DYNLL1, MRPS22, PITPNB, IST1, POLR2C, S100A8, RARS, CDC37, TIMM13, AP3S1, ECHS1, ANXA7, MRPS31, DAP3, TRMT10C, EIF2B1, MTHFD1, ERH, STK26, TRIM28, SNX1, COPS8, API5, TXN, PRPS1, AIMP2, CSNK2B, NACA, RAB11A, MACROD1, EIF3K, CXCL14, PTMA, UBE2S, NFKBIE, CCDC124, MIF, SEPT2, YWHAH, IARS, FEN1, ACTN1, ARCN1, NHP2L1, H2AFV, SNX2, NAP1L1, NDUFS3, ADRM1, RPL27, EIF4A3, PFN1, PFN2, ACTN4, FASN, FBL, ELAVL1, LDHAL6A, CD3EAP, MCM4, NOLC1, STOML2, CPSF6, DDX1, JUP, RBMXL2, PSMC5, FMR1, RAB5C, RPL10A, ENO3, ETF1, EIF3C, ATXN10, XRCC5, PRPF19, FARSA, DKC1, DSP, PPM1G, DDX23, EIF3D, TPM1, SRRT, CTNNA1, SND1, AASDHPPT, AIMP1, PYCR2, MRPS35, GART, STRAP, TWF1, EIF2B2, PNN, CSTF3, CDK9, H2AFY, GALK1, MAT2A, DNAJA1, MAP2K2, MCM3, MCM6, SMARCE1, IRS4, HSPA4, DDX39B, HSPH1, SEPT7, RSL1D1, SUPT16H, PSMD3, EHD1, UBAP2L, LARP1, EIF2AK2, LARS, GATAD2A, EIF3A, QARS, EIF4G1, ELP2, DSC1, ZC3HAV1, BCLAF1, THRAP3, SMC3, COPA, HDLBP, ACIN1, PARK7, SOAT1, HIST1H2AE, HIST1H2AB, AK4, C21orf33, HIST1H2BD, HIST1H2BG, HIST1H2BF, HIST1H2BE, HIST1H2BI, HIST1H2BC, SMN1, SMN2, BOLA2, BOLA2B | SHPRH | FDFT1, FBXW7, USP36, USP49, RAD18, HLTF, UBE2V2, UBE2N, UBE2A, PCNA, DTL, C17orf59, EDARADD, RBBP7, HIST1H3A, HIST1H4A, POLR1A, UBTF |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for DLD_SHPRH |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for DLD_SHPRH |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | DLD | C0268193 | NADH cytochrome B5 reductase deficiency | 8 | ORPHANET;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|